Today: 9 April 2026
Barclays share price today: Stock slips after fresh buyback update as tariff jitters linger
21 January 2026
1 min read

Barclays share price today: Stock slips after fresh buyback update as tariff jitters linger

London, Jan 21, 2026, 08:02 GMT — Regular session.

  • Barclays shares slipped in early London trading Wednesday.
  • The bank announced a fresh wave of buyback purchases, confirming the shares will be cancelled.
  • Traders are focused on tariff news and policy cues ahead of bank earnings season.

Shares of Barclays PLC dipped in early London trading Wednesday following the announcement of a new round of share buybacks, as trade tensions kept investors on edge.

This update is significant because buybacks offer banks a direct, rapid method to return surplus capital. Investors frequently interpret them as a gauge of confidence and available balance-sheet capacity.

Barclays faces a turbulent backdrop. Bank shares have been volatile amid shifting rate forecasts and political uncertainty, and a quiet market can quickly sour as tariffs and geopolitical tensions drive investors to safer bets.

Barclays (BARC.L) slipped around 0.6% to 476.7 pence, following a close of 479.6 pence on Tuesday. So far on Wednesday, shares have fluctuated between about 476.4 and 479.2 pence, remaining under their 52-week peak close to 492.95 pence, according to Investing.com data.

The bank acquired 2,504,922 ordinary shares on Jan. 20 under a buyback scheme announced on Oct. 23, 2025, paying a volume-weighted average price of 478.7390 pence each. Barclays intends to cancel these shares, bringing total repurchases since the programme’s inception to 83,880,969 shares at an average price of 460.8814 pence. Investegate

JPMorgan boosted its price target on Barclays to 570 pence, maintaining the stock as its “highest conviction idea” ahead of the fourth-quarter results, according to an Investing.com report. The firm highlighted return on tangible equity—a key profitability metric—as a critical focus for the upcoming investor update. Investing.com

London’s FTSE 100 dropped 0.72% on Tuesday, weighed down by geopolitical jitters. U.S. President Donald Trump warned of a 10% tariff hike on imports from eight European nations, including Britain, starting Feb. 1—unless the U.S. gets a chance to buy Greenland, Reuters reported. “Geopolitical tensions have dented sentiment,” Nuveen senior macro strategist Laura Cooper told Reuters. Reuters

Barclays’ investment bank has popped up in recent deal talks. On Monday, Zurich Insurance revealed a $10.3 billion bid for specialty insurer Beazley. Barclays is listed as one of Beazley’s advisers, according to a Reuters report. Reuters

Buybacks and bullish broker targets often get overshadowed when volatility jumps. A sudden risk-off wave can slam lenders with slower deal flow and weaker borrowing demand. At the same time, shifts in rate forecasts can alter net interest income — the difference between bank earnings on loans and their costs on deposits.

Politics are the next trigger. Reuters’ global markets wrap noted Wall Street’s steep drop overnight, fueling chatter about a “Sell America” move; Westpac senior economist Mantas Vanagas said investors are pulling back from U.S. assets. All eyes turn to Trump’s World Economic Forum speech in Davos on Wednesday (Jan. 21) and an EU emergency summit in Brussels on Thursday (Jan. 22) for hints on whether the tariff conflict will ease or intensify. Reuters

Stock Market Today

  • AbbVie's Humira Launch on TrumpRx with 86% Discount Sparks Valuation Questions
    April 9, 2026, 9:02 AM EDT. AbbVie (NYSE:ABBV) has introduced Humira on the TrumpRx platform at an 86% discount under a White House pricing deal aiming to reduce patient costs and widen drug access. This marks a significant US pricing strategy shift post exclusivity for Humira, a key immunology therapy driving substantial revenue. The stock trades near $206.69, about 20% below analyst targets and 43.8% under fair value estimates. The deep discount could alter patient volume, payer ties, and pricing benchmarks in government-linked drug programs. AbbVie's revenue exposure of $61.2 billion and a high price-to-earnings ratio of 87.3 place focus on potential impacts to cash flow and dividends amid its debt load. Investors should monitor reactions from payers, competitors, and capital markets to this pricing shift that could redefine AbbVie's US market dynamics.

Latest article

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

9 April 2026
Brent crude rebounded 3% Thursday despite a U.S.-Iran ceasefire, with the Strait of Hormuz still nearly shut and only one oil-products tanker passing in 24 hours. U.S. gasoline averaged $4.166 a gallon on April 9, and AAA said prices could drop slowly. North Sea Forties crude hit a record $146.43 a barrel. The U.S. EIA expects Hormuz flows may take months to recover.
CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

9 April 2026
CoreWeave said Meta Platforms committed about $21 billion for AI cloud capacity through December 2032. Shares rose 4.3% to $88.90 in premarket trading after the announcement. The deal follows an $8.5 billion loan facility and a $1.25 billion senior notes offering. CoreWeave reported $5.13 billion in 2025 revenue and ended December with a $66.8 billion backlog.
NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

9 April 2026
TrendForce said April 8 that Nvidia’s Rubin AI chip shipments may be delayed by HBM4 memory qualification and cooling demands, shifting over 70% of 2026 high-end GPU volume to the current Blackwell line. Rubin’s projected share dropped to 22%. Samsung began shipping HBM4 to Nvidia in February, but SK Hynix and Micron face qualification delays. Broadcom signed a long-term deal to develop Google’s TPUs through 2031.
Anglo American shares jump early as metals rally and tariff fears jolt markets
Previous Story

Anglo American shares jump early as metals rally and tariff fears jolt markets

BP share price today: BP stock edges up after buyback update as oil prices slip
Next Story

BP share price today: BP stock edges up after buyback update as oil prices slip

Go toTop